A live audio webcast of the presentation will be available by accessing DURECT's homepage at http://www.durect.com and clicking "Investor Relations". If you are unable to participate during the live webcast, the call will be archived on DURECT's website under Audio Archive in the "Investor Relations" section.
Webcast Link: http://www.wsw.com/webcast/jeff18/drrx
About DURECT Corporation
DURECT Corporation is an emerging specialty pharmaceutical company developing pharmaceutical systems based on its proprietary drug delivery platform technologies. The Company currently has a number of late-stage pharmaceutical products in development addressing large markets in pain management, with a number of research programs underway targeting chronic disease and other therapeutic areas. For more information, please visit http://www.durect.com.
SOURCE DURECT Corporation
Matthew J. Hogan, Chief Financial Officer of DURECT Corporation, +1-408-777-4936; or
media, Jeremiah Hall, Senior Vice President of Feinstein Kean Healthcare,